Russell Investments Group, Ltd. Lyell Immunopharma, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$1.3 - $3.01 $10,476 - $24,257	8,059 Added 235.85%	11,476 $16,000
Q1 2024 May 08, 2024	BUY	$1.71 - $3.07 $5,843 - $10,490	3,417 New	3,417 $7,000
Q2 2023 Aug 10, 2023	SELL	$1.89 - $3.86 $93,451 - $190,857	-49,445 Reduced 69.89%	21,298 $67,000
Q1 2023 May 09, 2023	BUY	$1.97 - $3.58 $139,363 - $253,259	70,743 New	70,743 $166,000

122

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $273M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.